Haloperidol Selectively Remodels Striatal Indirect Pathway Circuits

Luke E. Sebel, Steven M. Graves, C. Savio Chan, D. James Surmeier

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


Typical antipsychotic drugs are widely thought to alleviate the positive symptoms of schizophrenia by antagonizing dopamine D 2 receptors expressed by striatal spiny projection neurons (SPNs). What is less clear is why antipsychotics have a therapeutic latency of weeks. Using a combination of physiological and anatomical approaches in ex vivo brain slices from transgenic mice, it was found that 2 weeks of haloperidol treatment induced both intrinsic and synaptic adaptations specifically within indirect pathway SPNs (iSPNs). Perphenazine treatment had similar effects. Some of these adaptations were homeostatic, including a drop in intrinsic excitability and pruning of excitatory corticostriatal glutamatergic synapses. However, haloperidol treatment also led to strengthening of a subset of excitatory corticostriatal synapses. This slow remodeling of corticostriatal iSPN circuitry is likely to play a role in mediating the delayed therapeutic action of neuroleptics.

Original languageEnglish (US)
Pages (from-to)963-973
Number of pages11
Issue number4
StatePublished - Mar 1 2017

Bibliographical note

Funding Information:
This work was supported by NIMH P50 MH090963, NS34696, NS084735, and the JPB Foundation.

Fingerprint Dive into the research topics of 'Haloperidol Selectively Remodels Striatal Indirect Pathway Circuits'. Together they form a unique fingerprint.

Cite this